Gabriela Georgieva Panayotova

Dr. Gabriela Georgieva Panayotova

Physiology and Pathophysiology, Medical University of Varna, Varna, Bulgaria
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Gabriela Georgieva PanayotovaGabriela Georgieva Panayotova
Gabriela Georgieva Panayotova
Background/Objectives: Artificial intelligence (AI) has emerged as a transformative force in healthcare, with nutrition and dietetics becoming key areas of application. AI technologies are being employed to enhance dietary assessment, personalize nutrition plans, manage chronic diseases, deliver virtual coaching, and support public health nutrition. This review aims to critically synthesize the current literature on AI applications in nutrition, identify research gaps, and outline directions for future development. Methods: A systematic literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar for peer-reviewed publications from January 2020 to July 2025. The search included studies involving AI applications in nutrition, dietetics, or public health nutrition. Articles were screened based on predefined inclusion and exclusion criteria. Thematic analysis grouped findings into six categories: dietary assessment, personalized nutrition and chronic disease management, generative AI and conversational agents, global/public health nutrition, sensory science and food innovation, and ethical and professional considerations. Results: AI-driven systems show strong potential for improving dietary tracking accuracy, generating personalized diet recommendations, and supporting disease-specific nutrition management. Chatbots and large language models (LLMs) are increasingly used for education and support. Despite this progress, challenges remain regarding model transparency, ethical use of health data, limited generalizability across diverse populations, and underrepresentation of low-resource settings. Conclusions: AI offers promising solutions to modern nutritional challenges. However, responsible development, ethical oversight, and inclusive validation across populations are essential to ensure equitable and safe integration into clinical and public health practice.

7 September 2020 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MPMilena Peruhova
Milena Peruhova
Monika Peshevska-SekulovskaMonika Peshevska-Sekulovska
Monika Peshevska-Sekulovska
VGViktoriya Georgieva
Viktoriya Georgieva
Gabriela Georgieva PanayotovaGabriela Georgieva Panayotova
Gabriela Georgieva Panayotova
DDDorian Dikov
Dorian Dikov
Surveilling Russell body Helicobacter pylori-negative gastritis: A case report and review of literature

22 April 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
AHAntoniya Hachmeryan
Antoniya Hachmeryan
Gabriela Georgieva PanayotovaGabriela Georgieva Panayotova
Gabriela Georgieva Panayotova
HTHristiyana Todorova
Hristiyana Todorova
Background: Nutritional psychiatry increasingly links diet quality and specific bioactive nutrients to depression and anxiety outcomes. Mechanistic evidence implicates neuroimmune activation, inflammation, altered neurotransmitter synthesis, and microbiota-derived metabolites. Objective: The objective of this study is to synthesize evidence on omega-3 polyunsaturated fatty acids (n-3 PUFAs), the microbiota–gut–brain axis, and vitamins and minerals that influence neurotransmitter synthesis, inflammation, and brain function and to translate these findings into food-based strategies. Methods: This study consisted of a focused synthesis of randomized controlled trials (RCTs), meta-analyses, and systematic reviews indexed in PubMed, Scopus and Web of Science, selected for relevance to omega-3s, probiotics/prebiotics, dietary patterns, and micronutrients (folate/B-vitamins, vitamin D, magnesium, zinc, and vitamin C/copper pathways). Results: RCT and meta-analytic evidence suggest modest benefits of omega-3 supplementation for anxiety severity and depressive symptoms, with heterogeneity by dose, EPA: DHA composition, and baseline inflammatory status. The gut–brain axis literature supports bidirectional effects of stress and microbiota, and meta-analyses of probiotics/prebiotics show small improvements in depressive and anxiety symptoms, likely dependent on strain and host phenotype. Micronutrients serve as enzymatic cofactors for monoamine and GABA synthesis and modulate immune signaling; clinical effects are the most consistent when correcting insufficiency or in biomarker-defined subgroups. A whole-diet RCT demonstrates that structured dietary improvement can reduce depressive symptoms as adjunctive therapy. Conclusions: A food-first approach emphasizing Mediterranean-style dietary patterns, omega-3-rich seafood, a diverse array of fiber, and micronutrient density is the most defensible. Supplementation may be considered selectively, guided by clinical context and nutritional status.

20 May 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
Gabriela Georgieva PanayotovaGabriela Georgieva Panayotova
Gabriela Georgieva Panayotova
AHAntoniya Hachmeryan
Antoniya Hachmeryan
Background: Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental condition with psychosocial impact. Dietary carbohydrates, particularly added sugars, refined starches, and high-glycemic index/load (GI/GL) patterns, have been proposed as modifiable exposures that may relate to attention and behavioral regulation. This systematic review synthesized evidence linking carbohydrate quantity and quality to ADHD-related outcomes. Methods: Following PRISMA 2020, PubMed, Scopus, and Web of Science were searched for English-language studies published from January 2015 to December 2025. Eligible studies included observational and interventional designs in children, adolescents, or adults with a clinical ADHD diagnosis or validated symptom assessment. Risk of bias was assessed using NOS/NOS-adapted criteria, RoB 2, and ROBINS-I. Findings were synthesized narratively by exposure domain. Results: Of 1174 records identified, 48 studies were included: 38 observational and 10 interventional. Sugar-related exposures showed the most consistent pattern: 15 of 16 studies examining added sugars, sugar-sweetened beverages, sweets, candy, or sweet dietary patterns reported positive associations with ADHD diagnosis, symptom severity, hyperactivity, or less favorable ADHD-related outcomes. Findings for total carbohydrate intake were inconsistent. GI/GL-specific evidence was limited but generally adverse in direction. Among intervention studies, symptom improvement after modification was reported in 6 of 10 studies, whereas 4 studies showed mixed, preliminary, non-significant, or non-superior findings. Most observational studies showed moderate to high risk of bias, while interventional studies showed variable risk across domains. Conclusions: Poorer carbohydrate quality may be associated with greater ADHD-related symptom burden, whereas total carbohydrate intake showed inconsistent associations. Certainty remains limited by heterogeneity, residual confounding, risk of bias, and limited carbohydrate-specific intervention evidence.

4 February 2026 in BioMedInformatics
Verified
Journal Article
Open access
PDF file
Gabriela Georgieva PanayotovaGabriela Georgieva Panayotova
Gabriela Georgieva Panayotova
Background/Objectives: Software is now core infrastructure in biomedical science, yet fragmented workflows across subfields hinder reproducibility and delay the translation of data into actionable decisions. There is a critical need for a cross-disciplinary synthesis to bridge these silos and establish a unified framework for software maturity. This narrative review addresses this gap by synthesizing representative software ecosystems across three major pillars: bioinformatics, molecular modeling/simulations, and epidemiology/public health. Methods: A narrative review of articles indexed in PubMed/NCBI, Web of Science, and Scopus between 2000 and 2025 was conducted. Domain-specific terms related to bioinformatics, molecular modeling, docking, molecular dynamics, epidemiology, public health, and workflow management were combined with software- and algorithm-focused keywords. Studies describing, validating, or applying documented tools with biomedical relevance were included. Results: Across domains, mature data standards and reference resources (e.g., FASTQ, BAM/CRAM, VCF, mzML), widely adopted platforms (e.g., BLAST+ (v2.16.0, NCBI, Bethesda, MD, USA), Bioconductor (v3.20, Bioconductor Foundation, Seattle, WA, USA), AutoDock Vina (v1.2.5, Scripps Research, La Jolla, CA, USA), GROMACS (v2024.3, GROMACS Team, Stockholm, Sweden), Epi Info (v7.2.6, CDC, Atlanta, GA, USA), QGIS (v3.40, QGIS.org, Gossau, Switzerland), and increasing use of workflow engines were identified. Software pipelines routinely transform molecular and surveillance data into interpretable features supporting hypothesis generation. Conclusions: Integrated, standards-based, and validated software pipelines can shorten the path from measurement to decision in biomedicine and public health. Future progress depends on reproducibility practices, benchmarking, user-centered design, portable implementations, and responsible deployment of machine learning.

12 March 2025 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
AHAntoniya Hachmeryan
Antoniya Hachmeryan
NSNadezhda Stefanova
Nadezhda Stefanova
Gabriela Georgieva PanayotovaGabriela Georgieva Panayotova
Gabriela Georgieva Panayotova
Introduction: Epidemiologic, experimental, and clinical data support a link between type 2 diabetes mellitus (T2DM) and dementia due to Alzheimer's disease (AD). The prevalence of both T2DM and AD increases with age, and both diseases are chronic and are among the leading causes of morbidity and mortality. AD incidence in late diabetic patients is two times higher compared with normal elderly people and is thought to arise from impaired insulin secretion and resistance, leading to nervous system damage and ultimately influencing cognitive function in patients. Material and methods: Using representative keywords, we conducted a comprehensive search in the scientific web databases PubMed and Scopus and limited the publication date of the papers to the last 10 years. Results: Insulin resistance (IR) causes long-term neuronal exposure to a high-level insulin environment, leading to neuronal degeneration and irreversible memory impairment. The review of the literature outlined several possible mechanisms for IR and cognitive dysfunction interplay: (1) IR affects hippocampal plasticity, (2) IR contributes to altered amyloid precursor protein (APP) metabolism, (3) IR is related to elevated tau protein concentration, (4) IR affects brain inflammatory reaction, (5) oxidative stress is identified as an early event in the development of brain IR, and (6) genetic factors, related to ApoE ε4 allele expression and IR are present. Conclusion: Although secreted peripherally, insulin plays a profound role in cognitive function, and IR facilitates the brain's susceptibility to neurodegeneration. The brain insulin signaling pathways also offer a promising therapeutic target for managing cognitive disorders.